NCT02640625View on ClinicalTrials.gov

Improving Prognosis in HIV Infection

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

April 30, 2017

Conditions
Human Immunodeficiency Virus
Interventions
DIETARY_SUPPLEMENT

Probiotic compound

Lactobacillus rhamnosus GG, Lactobacillus acidophilus, Lactobacillus bulgaricus, Bifidobacterium animalis subsp. lactis, and Streptococcus thermophilus.

Trial Locations (1)

0424

Oslo University Hospital (Ullevaal campus), Oslo

All Listed Sponsors
collaborator

University of Oslo

OTHER

lead

Oslo University Hospital

OTHER

NCT02640625 - Improving Prognosis in HIV Infection | Biotech Hunter | Biotech Hunter